ArticleCureus2025
Systemic Lupus Erythematosus Presenting With Hemoptysis at Onset in an Elderly Male.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic lupus erythematosus (SLE) is a connective tissue disorder with an unknown cause that primarily impacts women of reproductive age. We present a case of a new-onset elderly male SLE with positive anti-nuclear antibodies (ANAs) and clinical presentations including hemoptysis, fatigue, weight loss, multiple skin and mucosal lesions, and intractable pyrexia. The European League Against Rheumatism guidelines and comprehensive evaluations were used to establish a diagnosis of SLE. The prevalence of SLE in males is lower compared to women, often presenting with negative ANA, which makes diagnosis challenging. An unusual and striking feature in this case was hemoptysis as the initial presenting symptom, a rare manifestation that highlights the need for heightened suspicion. Thus, having a high degree of suspicion as a primary care doctor helps in early diagnosis, improves treatment outcomes, and leads to a better quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.